Fact.MR – A Market Research and Competitive Intelligence Provider: As per a recent analysis published by Fact.MR, the global COVID-19 saliva-based detection kits market is expected to total US$ 1.6 billion in 2021 in comparison to the US$ 1.4 bn worth valuation registered in 2020.
Polymerase Chain Reaction-based Kits to Remain Most Adopted for COVID-19 Testing, Accounting for 70% of COVID-19 Saliva-based Detection Kits Sales in 2021
In its latest study on the COVID-19 saliva-based detection kits, Fact.MR provides insights into factors propelling the demand across key segments in terms of product, technology, application, and end user. The report also shed light on critical trends and opportunities elevating growth prospects for the COVID-19 saliva-based detection kits market for the forthcoming decade
Fact.MR – A Market Research and Competitive Intelligence Provider: As per a recent analysis published by Fact.MR, the global COVID-19 saliva-based detection kits market is expected to total US$ 1.6 billion in 2021 in comparison to the US$ 1.4 bn worth valuation registered in 2020.
The market is primarily driven by the rising prevalence of the novel coronavirus and the outbreak of mutant variants of the virus such as Delta (B.1.617.2), Alpha. (B.1.1.7), Beta (B.1.351) and Gamma (P.1) across the world.
Increasing demand for effective COVID-19 diagnosis techniques and therapeutics for prompt treatment and growing awareness regarding the importance of early diagnostics are expected to create opportunities for growth. In addition to this, recent approvals on the use of novel diagnostic kits by international organizations are favoring the market growth.
For instance, the U.S. Food and Drug Administration (FDA) issued authorization on the use of OMNIgene® Oral, developed by a Biotechnology company, DNA Genotek’s, as COVID-19 testing kit. Such developments and slew of product launches witnessed over the last few months created a conducive environment for the expansion of the market.
For More Information On How To Improve Your COVID-19 Saliva-Based Detection Kits Market Footprint, Request A Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=6902
As per Fact.MR, polymerase chain reaction (PCR)-based kits are projected to dominate the market in terms of product type. The segment is expected to account for nearly 70% of the overall sales by 2031. This can be attributed to the product ability to offer real-time diagnosis and accurate detection of the SARS-CoV-2 coronavirus.
“With growing awareness regarding home-based testing of SARS COV-2 infection and rising adoption of COVID-19 diagnostic kits across the hospitals and clinics, leading manufacturers are encouraged to launch novel real-time diagnostics solutions. This is expected to drive the market in the coming year,” says a Fact.MR analyst.
Key Takeaways from the COVID-19 Saliva-based Detection Kits Market Study
- The U.S. is projected to account for nearly 91% of the sales in the North America market, owing to rising awareness regarding early detection of SARS-COV-2 using saliva.
- Due to the high prevalence of new COVID-19 variant in the country, Italy is anticipated to dominate the market in Europe, accounting for over 27% of demand in 2021.
- China is forecast to emerge as the most lucrative market in East Asia, contributing more than 89% of the sales in the region in 2021.
- Based on technology, RT-qPCR is expected to hold over 49% of the overall sales in 2021, favored by the rising demand for point-of-care testing (POCT).
- In terms of application, COVID-19 diagnosis is estimated to remain as the most remunerative segment, accounting for 63.1% of the market share in 2021.
Key Drivers
- Implementation of government regulations, mandating the diagnosis and vaccination for COVID-19 is spurring the sales of COVID-19 saliva-based detection kits.
Key Restraints
- Increasing usage of blood and nasopharyngeal swabs for coronavirus detection is hampering the sales of COVID-19 saliva-based detection kits.
- Less accurate detection of lateral flow assays compared to other technologies such as RT-qPCR is hinder the segment growth.
Ask Your COVID-19 Saliva-Based Detection Kits Market Related Questions & Get Customized Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6902
Competitive Landscape
Leading players in the global market are emphasizing on adopting organic and inorganic strategies such as new product launch, product approval, acquisition, agreement, and collaborations to expand their product portfolio and strengthen their market presence. For instance,
- In April 2021, Chembio Diagnostics, Inc. announced receiving approval form the U.S. FDA for its new rapid POCT kits for COVID-19/Flu A&B testing.
- In January 2021, Thermo Fisher Scientific announced acquiring a hand-held test devices manufacturers for COVID-19 detection, Mesa Biotech. The acquisition will assist the company to improve access to reliable and accurate POCT advanced molecular diagnostics.
Some of the key players in the market profiled by Fact.MR are:
- Thermo Fisher Scientific Inc
- Qiagen
- Hologic
- Takara Bio Inc
- Arcis Biotechnology Limited
- GeneProof
- Abacus ALS
- Kolplast Group
- Vitagene
- Therma Bright Inc
- ACON Laboratories, Inc
- Assure Tech. (Hangzhou) Co., Ltd
- KYODO INTERNATIONAL INC.
- Zymo Research Corporation.
- Salimetrics
More Valuable Insights on COVID-19 Saliva-Based Detection Kits Market
Fact.MR, in its new report, offers an unbiased analysis of the global COVID-19 saliva-based detection kits market, analyzing statistics through 2021 and beyond. The survey reveals growth projections on COVID-19 saliva-based detection kits market with detailed segmentation:
- By Product
- Rapid Test Kits
- PCR-based Kits
- By Technology
- Direct Sample to PCR
- RT-qPCR
- Lateral Flow Assays
- By Application
- COVID-19 Research
- COVID-19 Diagnostics
- By End User
- Diagnostic Laboratories
- Hospitals & Clinics
- Academic and Research Institutes
- Biopharma Companies
- Long Term Care Facilities
- Home Care Settings
- Others
Key Questions Covered in the COVID-19 Saliva-Based Detection Kits Market Report
- The market survey also highlights projected sales growth of the COVID-19 saliva-based detection kits market between 2021 and 2031
- The report offers insight into COVID-19 saliva-based detection kits demand outlook for 2021-2031
- COVID-19 saliva-based detection kits market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- COVID-19 saliva-based detection kits market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain
Polymerase Chain Reaction Market - Rising investments in genetic engineering research and development, as well as competition for the discovery of new drugs for diseases such as HIV/AIDS and cancer, will boost growth prospects. PCR adoption in the pharmaceutical and biotechnology industries is expected to grow at an impressive 8.6 percent CAGR during the forecast period. The demand for PCR in clinical diagnostic labs and hospitals is expected to skyrocket.
PCR and Real-time PCR Molecular Diagnostics Market - The COVID-19 pandemic has boosted prospects for the growth of the PCR and real-time PCR molecular diagnostics market. Real-time (qPCR) and digital (dPCR) PCR tests have been used in a variety of healthcare settings to detect and diagnose potential cases. Because of its high sensitivity, healthcare providers have embraced PCR tests on a large scale. As a result of such trends, the global PCR and real-time PCR molecular diagnostics market is poised to soar to new heights, surpassing a significant revenue threshold in the coming decade.
Home Diagnostics Market - Home diagnostics is a burgeoning market that is rapidly gaining traction in a world grappling with the COVID-19 pandemic. Home diagnostic kits, which are armed with advanced technology, allow users to check and monitor their health conditions in the comfort of their own homes. The United States of America had the largest market share of home diagnostics in North America, accounting for approximately 40% of market revenue, and is expected to maintain its lead throughout the forecast period.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR